Cloxestradiol

This classification denotes a therapeutic estrogen with the molecular formula C20H25Cl3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 42R9MZG1DL, chemically known as 17 beta-(2,2,2-trichloro-1-hydroxyethoxy)estra-1,3,5(10)-trien-3-ol. but generally known as cloxestradiol, which bears US NIH Compound Identifier 194705. European Medicines Agency schedules Cloxestradiol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06782MIG. The term CLOXESTRADIOL is an International Non-Proprietary Name. CLOXESTRADIOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cloxestradiol under HS 29372300 and SITC 54153. As of Q4 2014, CLOXESTRADIOL remains the US FDA Preferred Term for this commodity. Cloxestradiol bears US NLM identifiers UMLS ID C2699388 and NCI Concept Code C79721. SMILES: ClC(Cl)(Cl)C(OC1C2(C(C3C(CC2)c2c(CC3)cc(O)cc2)CC1)C)O.